Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia

PURPOSE: Dyslipidemia frequently occurs in schizophrenia patients treated with antipsychotic drugs (APDs), especially atypical APDs. Apolipoprotein A1 (ApoA1) plays a key role in lipid metabolism. The aim of this study was to investigate whether ApoA1 gene polymorphisms are associated with APD-induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Lin, You, Yiwen, Fan, Yao, Shen, Chong, Xue, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096449/
https://www.ncbi.nlm.nih.gov/pubmed/33958870
http://dx.doi.org/10.2147/NDT.S305200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096449/
https://www.ncbi.nlm.nih.gov/pubmed/33958870
http://dx.doi.org/10.2147/NDT.S305200

Ejemplares similares